Saturday, February 27, 2021
HEALTH CARE
SHOP
  • Home
  • Health & Fitness
  • Disease
  • Healthy Diet
  • Yoga
  • Lose Weight
  • Gain Weight
  • Men Health
  • More
    • Pregnant & Baby Care
No Result
View All Result
Health Care
No Result
View All Result
Home Disease

Leuven researchers report progress in slowing disease

Health Care by Health Care
October 11, 2020
in Disease
0
Leuven researchers report progress in slowing disease
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter
Loading......
 


High doses of the antiviral medication favipiravir have shown good results in stopping the progress of the Covid-19 infection in hamsters, according to a new paper by researchers from the Rega Institute at the university of Leuven.

Favipiravir is commonly used in Japan to fight the seasonal flu, but is less well-known here. The Rega team – Professor Johan Neyts, research associate Dr. Suzanne Kaptein, assistant professor Leen Delang and researcher Dr. Joana Rocha-Pereira – compared the drug with the much better-known hydroxychloroquine, using hamsters.

The animals were given either hydroxychloroquine or favipiravir, and those who received favipiravir were given various doses. Some hamsters were infected directly via the nose, while others were infected by being placed in a cage with an infected animal.

After four days, the disease progress in each of the animals was measured.

What the team found was that virtually no virus remained in the animals that had received large doses of favipiravir, regardless of the manner of infection. The effect was missing, however, in animals that had received low doses.

“It was the high dose that made the difference,” Prof. Delang said. “That’s important to know, because there are international clinical studies set up to test favipiravir on humans.”

As far as the animals that had received hydroxychloroquine were concerned, on the other hand, no such positive effect was recorded.

“Despite the lack of clear evidence in animal models or clinical studies, many COVID-19

patients have already been treated with hydroxychloroquine,” explained Dr. Rocha-Pereira.

“Based on these results and the results of other teams, we advise against further exploring the use of hydroxychloroquine as a treatment against COVID-19.”

The research by the Rega Institute team is published in the journal PNAS.

Alan Hope
The Brussels Times



Source link

 

Tags: DiseaseLeuvenprogressreportResearchersslowing
Advertisement Banner
Previous Post

How to gain weight and muscle mass naturally: pack on weight easier following THESE mass gaining tips

Next Post

The Best Gym 2020 Results | RTD The Best 2019 Winners – Health & Beauty

Health Care

Health Care

Next Post
The Best Gym 2020 Results | RTD The Best 2019 Winners – Health & Beauty

The Best Gym 2020 Results | RTD The Best 2019 Winners - Health & Beauty

Discussion about this post

Categories

  • Disease
  • Gain Weight
  • Health & Fitness
  • Healthy Diet
  • Lose Weight
  • Men Health
  • Pregnant & Baby Care
  • SHOP
  • Uncategorized
  • Yoga
Mediterranean Diet Secrets New 2016 Update!

Mediterranean Diet Secrets New 2016 Update!

February 23, 2021
It’s a Sin Season 2: Rumors, Release Date, Spoilers

It’s a Sin Season 2: Rumors, Release Date, Spoilers

February 18, 2021
Rugby Lobby Group Led by Former Players Says the Game Need to Reform to Protect Players

Rugby Lobby Group Led by Former Players Says the Game Need to Reform to Protect Players

February 18, 2021

Follow us

Contact Us

  • Privacy & Policy
  • About US
  • Contact Us
  • Terms & conditions
  • DISCLAIMER

© 2020 Silver Shielding

No Result
View All Result
  • Home
  • Health & Fitness
  • Disease
  • Healthy Diet
  • Yoga
  • Lose Weight
  • Gain Weight
  • Men Health
  • More
    • Pregnant & Baby Care

© 2020 Silver Shielding

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy